Primer biliáris cholangitis (PBC): ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• PPAR 0
• TLR4 0
• AKT 0
• EGFR 0
• ERK 0
• GLP-1 0
• JAK 0
• JNK 0
• MDM2 0
• mTOR 0
• NLRP3 0
• PCSK9 0
• PD-1 0
• RUNX1 0
• STING 0
• TP53 0
• YAP 0

291 intézményből 24, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Leállított, visszavont és felfüggesztett vizsgálatok, a szponzor által a regiszterben megadott okkal, szó szerint idézve.

• Leállították

  TruGraf Liver Gene Expression Serial Test

  NCT06061341· Washington University School of Medicine· Frissítve: 2026. aug. 7.

  “Funding discontinued”A regiszter szövege, változtatás nélkül. Forrás

• Leállították

  To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

  NCT06488911· Intercept Pharmaceuticals· Frissítve: 2026. jún. 8.

  “Intercept made a business decision to terminate the study based on FDA's request for voluntary withdrawal of Ocaliva and the issuance of clinical hold on studies under US IND involving OCA.”A regiszter szövege, változtatás nélkül. Forrás

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Efficacy of Different Doses of Bezafibrate in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cholangitis

  NCT07926087· Instituto de Biotecnologia de Misiones· Forrás

• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

  NCT04526665· Ipsen· Forrás

• A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting Elafibranor

  NCT07906639· Ipsen· Forrás

• Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

  NCT01793168· Sanford Health· Forrás

• Elafibranor Pregnancy Surveillance Program: A Study to Evaluate the Safety of Elafibranor During Pregnancy

  NCT07556913· Ipsen· Forrás

• A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

  NCT06447168· Ipsen· Forrás

• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

  NCT06016842· Ipsen· Forrás

• A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

  NCT06730061· Ipsen· Forrás

• Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

  NCT06247735· Kowa Research Institute, Inc.· Forrás

• J-LINX: Japan LINerixibat eXtension Study

  NCT07860710· GlaxoSmithKline· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 1
• Organoids 1
• Mendelian Randomization Analysis 16
• Gene Expression Profiling 5
• Proteomics 5
• Metabolomics 4
• Mass Spectrometry 1
• Flow Cytometry 2
• Immunohistochemistry 3
• Liquid Biopsy 1
• Magnetic Resonance Imaging 3
• Machine Learning 4
• Cohort Studies 8
• Genome-Wide Association Study 17

• The increasing burden of primary biliary cholangitis-related cirrhosis in Mexico: Evidence from a contemporary multicenter cohort.

  Rev Gastroenterol Mex (Engl Ed), 2026. szept.

• Assessment of the Factors That Predict Post-Transplant Mortality in Autoimmune Liver Disease Recipients.

  Medicina (Kaunas), 2026. aug.

• Characterization of a Northern German Primary Biliary Cholangitis Cohort.

  Z Gastroenterol, 2026. júl.

• Autoimmune Diseases and Incident Spontaneous Subarachnoid Hemorrhage: A Swedish Population-Based Cohort Study.

  Neurology, 2026. febr.

• Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.

  BMJ Open Gastroenterol, 2025. dec.

• A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.

  Aliment Pharmacol Ther, 2020. máj.

• Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies.

  BMC Med, 2013. júl.

• Serum zinc concentrations in two cohorts of 153 healthy subjects and 100 cirrhotic patients from Mexico City.

  Dig Dis, 1995. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.